SEC Form 4 research
| Issuer | Kiniksa Pharmaceuticals International, plc |
|---|---|
| Tickers | KNSA |
| Reporting owners | 37 |
| Officers and directors | 5 |
| Last public filing | 2026-11-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-06 | 2026-11-04 | Patel Sanj K | S | 26,918 | $96.05 | Not reported |
| 2026-11-06 | 2026-11-04 | Patel Sanj K | S | 29,845 | $95.48 | Not reported |
| 2026-11-06 | 2026-11-04 | Patel Sanj K | S | 81,742 | $94.2 | Not reported |
| 2026-11-06 | 2026-11-04 | Patel Sanj K | S | 11,335 | $93.54 | Not reported |
| 2026-11-06 | 2026-11-04 | Patel Sanj K | S | 1,460 | $92.35 | Not reported |
| 2026-11-03 | 2026-10-30 | Patel Sanj K | S | 1,440 | $98.16 | Not reported |
| 2026-11-03 | 2026-10-30 | Patel Sanj K | S | 2,316 | $97.34 | Not reported |
| 2026-11-03 | 2026-10-30 | Patel Sanj K | S | 4,490 | $95.97 | Not reported |
| 2026-11-03 | 2026-10-30 | Patel Sanj K | S | 8,888 | $94.72 | Not reported |
| 2026-11-03 | 2026-10-30 | Patel Sanj K | S | 15,903 | $93.62 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.